**Specifications Table**TableSubject area*Pharmacology, Toxicology and Pharmaceutical Science*More specific subject area*Autism Spectrum DisorderToxicologyNatural products*Type of data*Table, Figures*How data was acquired*Animal behavior analysis and Reverse Transcription followed by Quantitative Polymerase Chain Reaction (RT-qPCR)*Data format*Analyzed*Experimental factors*The animal model of autism was induced by a single intraperitoneal injection of 600 mg/kg VPA or saline solution on embryonic day 12.5 (E12.5). RSV treatments were achieved by daily subcutaneous injections of RSV (3.6 mg/kg) or DMSO from E6.5 to E18.5. Blood samples from these animals were obtained by cardiac puncture 30 days after birth. Peripheral blood samples from autistic male individuals and from the control group (5--15 years-old range) were obtained at Clinical Hospital of Porto Alegre (HCPA).*Experimental features*Social Transmission of Food Preference (STFP) test was performed in male rats after food habituation, consumption of one of flavored food by demonstrator rat and interaction between demonstrator and observer rats. The amount of cued and non-cued food eaten by observers from each litter was weighed and recorded. After homogenization of blood samples, we performed RNA extraction and the mature miRNA expression was evaluated by reverse transcription followed by quantitative polymerase chain reaction (RT-qPCR), using fluorescence of SYBR Green to detect amplification, estimate Ct values and to determine specificity after melting curve analysis.*Data source location*Department of Biochemistry, Federal University of Rio Grande do Sul - UFRGS, Porto Alegre, RS, Brazil. Clinical Hospital of Porto Alegre, Porto Alegre, RS, Brazil.*Data accessibility*Hirsch, M. M. et al. Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA.* Food Chem. Toxicology 115 (2018): 336--343. doi: [10.1016/j.fct.2018.02.061](http://10.1016/j.fct.2018.02.061){#ir0005}.[@bib1]

**Value of the data**•Social transmission by absolute consumption of two flavored food in VPA-induced animal model of autism.•MicroRNA analysis in blood samples from male rats prenatally exposed to VPA and treated with RSV, compared to control animals.•MicroRNA analysis in blood samples from 5 to 15 years old autistic subjects.

1. Data {#s0005}
=======

[Fig. 1](#f0005){ref-type="fig"} presents the absolute food consumption of Wistar rats prenatally exposed to VPA, compared to the control animals, after treatment with RSV or vehicle. The animals exposed to VPA have a tendency to eat less of the flavored-food cued by demonstrator ([Fig. 1](#f0005){ref-type="fig"}A, *p*=0.080). On the other hand, animals presented no differences in consumption of alternative (non-cued) food across interventions ([Fig. 1](#f0005){ref-type="fig"}B, *p*=0.493).Fig. 1Absolute weights of consumed food in VPA autism model. Cued (A) and non-cued (B) food. Plots show medians±interquartile intervals. Statistical analysis: Independent-Samples Kruskal--Wallis test. Control (*n*=8), RSV (*n*=9), VPA (*n*=9), VPA+RSV (*n*=6).Fig. 1

We evaluated the relative expression of miRNA in blood of 30 days rats prenatally exposed to VPA or vehicle (saline) and treated with RSV or vehicle (DMSO). The GeNorm algorithm ranked miRNA miR181a-5p and miR181b-5p as the most stable ones and they were used as normalizers to evaluate the relative expression of the remaining miRNA. We observed no significant differences in levels of 13 miRNA ([Fig. 2](#f0010){ref-type="fig"}).Fig. 2Relative expressions of unchanged miRNA in peripheral blood of VPA autism model at P30. Plots presented as medians±interquartile intervals. Statistical analysis: Independent-Samples Kruskal--Wallis test. Control (*n*=6), RSV (*n*=6), VPA (*n*=6), VPA+RSV (*n*=5).Fig. 2

We also determined the relative expression of a set of miRNA in peripheral blood of autistic subjects, compared with controls in the same age-range (5--15 years). The GeNorm algorithm ranked miR23a-3p, miR146a-5p and miR181a-5p as the most stable ones and they were used as normalizers to evaluate the relative expression of the remaining miRNA. There were no intra-group differences related to age on miRNA levels. The analysis of relative expression revealed no significant differences in 11 miRNA in peripheral blood of autistic children, compared to control subjects ([Fig. 3](#f0015){ref-type="fig"}).Fig. 3Relative expressions of uncharged miRNA in peripheral blood of autistic children compared to control group. Results expressed as medians±interquartile intervals. Statistical analysis: Mann--Whitney U-test. Control (*n*=7) and autistic patients (*n*=7).Fig. 3

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Animal model of autism induced by VPA and resveratrol treatment {#s0015}
--------------------------------------------------------------------

The animal model of autism was induced as previously described [@bib2], [@bib3]. Briefly, female Wistar rats (UFRGS-Biochemistry Department CREAL), with controlled fertility cycles, were mated overnight. The first day of gestation was determined by the presence of spermatozoa in the vaginal smear (embryonic day 0.5). Pregnant females received a single intraperitoneal injection of 600 mg/kg VPA (sodium valproate, Sigma-Aldrich, USA) or saline solution on embryonic day 12.5 (E12.5), and daily subcutaneous injections of RSV (trans-resveratrol, Fluxome, Stenløse, Denmark, 3.6 mg/kg) or DMSO from E6.5 to E18.5 [@bib4]. Only males of the offspring were used in this study. Blood samples from these animals were obtained by cardiac puncture 30 days after birth. This project was approved by the local animal ethics committee (CEUA-UFRGS 140367/140431) and all animals were handled in accordance with established guidelines (National Council for the Control of Animal Experimentation (CONCEA)).

2.2. Evaluation of food consume in *STFP test* {#s0020}
----------------------------------------------

This experiment was adapted from Wrenn et al. protocol [@bib5]. Rats at 47 days of age were habituated for 72 h to eat pelleted food made from powdered chow. In the following day, food was removed three hours before the test. Next, one animal from each cage (demonstrator) was housed alone in a separate housing box and was allowed to eat a randomly assigned flavored food for 1 h: either cinnamon (1% w/w) or cocoa (2% w/w). Then the demonstrator rat was housed with their littermates (the observer rats) and allowed free interaction for 30 min. After this interaction period, the demonstrator animal was removed from the housing box and the observer animals were provided with two choices of powdered food in identical pellets, one with flavor of the cued food presented by demonstrator rat and the other with the alternative food. Rats were allowed to eat for one and a half hours, and the amount of cued and non-cued food eaten from each litter was weighed and recorded.

2.3. Blood samples from autistic and control subjects {#s0025}
-----------------------------------------------------

Peripheral blood samples from autistic male individuals and from the control group (5--15 years-old range) were obtained at the Clinical Hospital of Porto Alegre (HCPA). Inclusion criteria were age 5--15 years, have a clinical diagnosis of ASD according to DSM-5 and confirmed using the Autism Diagnostic Observation Schedule. Autistic individuals who presented secondary autism or autism as an associated feature to an identified genetic condition (Fragile X Syndrome, Rett Syndrome, Angelman Syndrome, Prader-Willi Syndrome, Smith-Lemli-Opitz Syndrome and Tuberous Sclerosis) were excluded from the study. This project was approved by the local ethics committee (CEUA-UFRGS 33863).

2.4. RNA extraction and RT-qPCR procedure {#s0030}
-----------------------------------------

After homogenization of blood samples with Trizol^®^ reagent (Invitrogen, USA), chloroform was added to perform phase separation, and RNA was precipitated from the upper aqueous layer using isopropanol. The precipitated RNA was washed with ethanol to remove impurities, resuspended in RNase-free water and stored at −80 °C [@bib6].

Mature miRNA expression was evaluated by reverse transcriptase followed by quantitative polymerase chain reaction (RT-qPCR) [@bib7]. Complementary DNA (cDNA) was synthesized from mature miRNA using reverse transcriptase reaction containing 2 µg of total RNA, 1 µL of 10 mM dNTP mix (Invitrogen, USA), 3 µL of stem loop RT primer mix (Supplementary Table 1), 4 µL M-MLV reverse transcriptase 5× reaction buffer (Invitrogen, USA), 2 µL of 0.1 M DTT (Invitrogen, USA), 1 µL of RNase inhibitor (Invitrogen, USA), 1.0 µL of M-MLV reverse transcriptase (Invitrogen, USA), and sterile distilled water to a final volume of 20 µL. The synthesis of the cDNA was completed after a sequence of three incubations at 65 °C for 5 min, 37 °C for 50 min and 70 °C for 15 min.

The quantitative PCR mix was comprised by 12 µL of cDNA (1:33), 1.0 µL of specific miRNA forward and universal reverse (10 µM) primers (as detailed in [Table 1](#t0005){ref-type="table"}), 0.5 µL of 10 µM dNTP mix, 2.4 µL of 10× PCR buffer (Invitrogen, USA), 0.8 µL of 50 mM MgCl~2~ (Invitrogen, USA), 2.4 µL of 1× SYBR^™^ Green (Molecular Probes, USA), 0.1 µL of Platinum Taq DNA Polymerase (Invitrogen, USA) and sterile distilled water to a final volume of 24 µL. The fluorescence of SYBR^™^ Green was used to detect amplification, estimate Ct values, and to determine specificity after melting curve analysis. PCR cycling conditions were standardized to 95 °C for 5 min followed by 40 cycles at 95 °C for 10 s, 60 °C for 10 s, and 72 °C for 10 s. After the main amplification, sample fluorescence was measured from 60 °C to 95 °C, with an increasing ramp of 0.3 °C each, to obtain the denaturing curve of the amplified products and Tm estimation, to assure their homogeneity after peak detection. Data was obtained from an Applied Biosystems StepOne System (USA). The set of 16 miRNA selected for this study includes miRNA involved in immunological and/or synaptic plasticity modulation, both processes altered in ASD and includes miRNA commonly altered in many neurodevelopmental disorders.Table 1Primer sequences for 16 miRNA evaluated. Forward and RT stem-loop primers and an universal reverse primer.Table 1**miRNA IDmiRNA sequencePrimer typePrimer sequences**miR132-3puaacagucuacagccauggucgForwardTCC GGC TAA CAG TCT ACA GCC ART stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC cgaccamiR138-5pagcugguguugugaaucaggccgForwardTCC GGA AGC TGG TGT TGT GAA TCRT stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC cggcctmiR125a-5pucccugagacccuuuaaccugugaForwardGTC GCG ATC CCT GAG ACC CTT TART stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC tcacagmiR195-5puagcagcacagaaauauuggcForwardGGG CGC TAG CAG CAC AGA AAT ART stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC gccaatmiR199a-5pcccaguguucagacuaccuguucForwardGAT GCG CCC AGT GTT CAG ACTRT stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC gaacagmiR134-5pugugacugguugaccagaggggForwardGGC TCT TGT GAC TGG TTG ACC ART stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC cccctcmiR124-3puaaggcacgcggugaaugccForwardCTA GCT TAA GGC ACG CGG TGART stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC ggcattmiR181a-5paacauucaacgcugucggugaguForwardGCG CTG AAC ATT CAA CGC TGT CRT stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC actcacmiR181b-5paacauucauugcugucgguggguForwardGCT GCG CAA CAT TCA TTG CTG TCRT stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC acccacmiR25-3pcauugcacuugucucggucugaForwardTCA GCA CAT TGC ACT TGT CTC GGRT stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC tcagacmiR21-5puagcuuaucagacugauguugaForwardCCG GCG CTA GCT TAT CAG ACT GATRT stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC tcaacamiR23a-3paucacauugccagggauuuccForwardGCT GTC ATC ACA TTG CCA GGG ART stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC ggaaatmiR146a-5pugagaacugaauuccauggguuForwardCGT GGC GTG AGA ACT GAA TTC CART stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC aacccamiR218-5puugugcuugaucuaaccauguForwardGCC GTC CTT GTG CTT GAT CTA ACCRT stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC acatggmiR30c-5puguaaacauccuacacucucagcForwardGCG TCG CTG TAA ACA TCC TAC ACT CRT stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC gctgagmiR191-5pcaacggaaucccaaaagcagcugForwardGGA GCG TCA ACG GAA TCC CAA AAGRT stem-loopGTC GTA TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACG AC cagctgReverse Universal PrimerReverseCCA GTG CAG GGT CCG AGG TA

2.5. Calculation of miRNA relative expression {#s0035}
---------------------------------------------

The RT-qPCR results were imported into Microsoft Excel and the geNorm program was used to assess the variance in expression levels of the miRNA analyzed [@bib8], [@bib9]. This program scanned the present miRNA two at a time. Then, the expression stabilities of the set of miRNA were evaluated. All miRNA were ranked accordingly to their stability. A pairwise variation analysis was performed by geNorm to determine the number of miRNA required for accurate normalization and to identify the most suitable miRNA to be used as normalizers.

The average value of crossing threshold (Ct) values (in triplicate) was converted to quantities for geNorm analysis by the difference between Ct values from two groups taken in each comparison. PCR efficiency was calculated from the slope of the amplification curve by exponential amplification analysis using the LinRegPCR algorithm [@bib10]. The relative expression was obtained using the −ΔΔCt method where Ct values of a group are subtracted from the average Ct values of the control group. The relative expression of miRNA was calculated considering the PCR efficiency and the --ΔΔCt values for each miRNA [@bib11] and were normalized to the normalizers identified by the geNorm software.

2.6. Statistical analysis {#s0040}
-------------------------

IBM SPSS Statistics 20.0 (IBM SPSS, Armonk, NY, USA) was used to perform the statistical analysis. Kolgomorov--Smirnov and Shapiro--Wilk tests of normality were applied to determine data distribution. The absolute consumption of each food flavor presented non-normal distribution, so that were compared by non-parametric Kruskal--Wallis test and the results expressed as median±interquartile interval. The miRNA relative expressions of the four animal groups were compared using non-parametric Kruskal--Wallis test and the results were expressed as median±interquartile interval. For the analysis of the human samples, non-parametric Mann--Whitney U-test was performed and the results were expressed as median±interquartile interval. All statistical analyses were supervised by the Biostatistics Unit at the Clinical Hospital of Porto Alegre.

Transparency document. Supplementary material {#s0050}
=============================================
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